Concepedia

Farzana L. Walcott

FL

10

Publications

368

Citations

10

H-Index

2002

Active since

Affiliations

National Cancer Institute(Current)

The University of Texas MD Anderson Cancer Center

AstraZeneca (United States)

University of Pittsburgh

The Barbara Ann Karmanos Cancer Institute

Farzana L. Walcott is an author at National Cancer Institute specializing in medicine, cancer research, and public health.

ORCID

Top concepts

Publications per year

2002–2020

10

Publications

10

Inhibiting mitochondrial respiration prevents cancer in a mouse model of Li-Fraumeni syndrome

Pingyuan Wang, Jie Li, Farzana L. Walcott et al. · Journal of Clinical Investigation · 2016 · 60 citations · Full text

, , +15

Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma

Shaji Kumar, Magdalini Migkou, Manisha Bhutani et al. · Blood · 2020 · 57 citations

A Case-Control Study of Dietary Phytoestrogens and Testicular Cancer Risk

Farzana L. Walcott, Michael Hauptmann, Cherie M. Duphorne et al. · Nutrition and Cancer · 2002 · 51 citations

, , +12

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

Lillian L. Siu, Joshua Brody, Shilpa Gupta et al. · Journal for ImmunoTherapy of Cancer · 2020 · 44 citations · Full text

Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1

Stephanie R. Land, Farzana L. Walcott, Qing Liu et al. · JNCI Journal of the National Cancer Institute · 2015 · 35 citations · Full text

Rows per page

1–5 of 10